Frankfurt Rhine-Main Metropolitan Area
Global Safety Strategy Lead Neurology, multiple sclerosis (since 2021): Cladribine/Mavenclad (deputy lead) Oncology (2016 - 2020): Avelumab: Merkel Cell Carcinoma; Avelumab combinations trials
Lead of a group of international PV Physicians. Act as a QPPV and consultant.
Heading of UK Medical Services Department (including Medical Monitors and PV Ops team); EEA-QPPV and consulting activities
Lead of a team of Medical PV Risk Assessors. Direct responsibility for the therapeutic areas: Gastroenterology, Diabetes, Lipidology, Orphan indications and Vitamins. Signal management; risk assessment, scientific advice, presentation of assessments to the PhVWP.